作者：张小丰

回复@格雷-lyu: 不知道啊，业绩很好。 BTK环比ABBV的-7.2%，AZ的+6.4%。这边是+18.4%，份额继续提升。//@格雷-lyu:回复@张小丰:那为何跌个不停

引用：

BTK的专利纠纷貌似要赢了。
The U.S. Patent and Trademark Office (USPTO) granted the Company’s petition for post-grant review of the Pharmacyclics’ patent asserted against the Company in a patent infringement suit, stating that the Company has shown that it is more likely...